Ultraslow SWL Versus Slow SWL for Renal Stones With High Attenuation Value

Ultraslow Full-power SWL Versus Slow SWL in Renal Stones With High Attenuation Value

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03795532

Acronym

ESWL

Enrollment

124

Registered

2019-01-07

Start date

2019-01-11

Completion date

2019-06-30

Last updated

2019-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Stones

Keywords

renal stones, SWL, High density stones, Ultraslow SWL, Slow SWL, Ramping, Pause

Brief summary

Ultraslow full-power SWL versus slow power-ramping SWL in Renal stones with high attenuation value

Detailed description

To evaluate the efficacy of ultraslow rate of SWL versus slow rate, power ramping SWL for renal stones

Interventions

PROCEDURESWL

Shock wave lithotripsy

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* single Renal stone less than or equal to 3 cm (2 cm for lower calyceal stones) * radio-opaque stone * high attenuation value (≥ 1000 HU) stone

Exclusion criteria

* Abnormal renal anatomy * renal insufficiency * solitary kidney * coagulopathies * uncontrolled hypertension * renal artery or aortic aneurysm * active urinary tract infection * pregnancy * severe skeletal malformations (spinal deformity) precluding proper stone localization * skin to stone distance (SSD) \> 11 cm * BMI \> 30 Kgm/m2

Design outcomes

Primary

Measure	Time frame	Description
stone free rate	3 months following last session of SWL	Complete clearance of stones in addition to clinically insignificant residual fragments

Secondary

Measure	Time frame	Description
Complications rate	3 months following last session of SWL	Comparison of rate of complications in both groups

Countries

Egypt

Contacts

Primary ContactMohammed S ElSheemy, Ass. Prof.

mohammedshemy@yahoo.com01006117755

Backup ContactAhmad Aref Al-Dessoukey, Ass. Prof.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026